Editor-in-Chief
Naranmandura Hua
Prof. , Zhejiang University, Hangzhou, Zhejiang · China
Editorial leadership for International Journal of Personalized Medicine
Research interests
- Pharmacology
- Hematology
Biography
- Hua Naranmandura is an professor in the Department of Toxicology, School of Medicine, Zhejiang University, China.
- He received his Ph.D degree in pharmacology and toxicology from Chiba University (Japan) and conducted his postdoctoral work at the University of Alberta (Canada).
- He is currently focusing on several topics like precision medicine especially emphasized on DNA aptamer based drug discovery; anticancer effects of arsenic trioxide and its metabolites on PML-RARA fusion protein degradation in acute promyelocytic leukemia (APL), etc.
- He also serves as editorial boards of Chemical Research in Toxicology, Toxicology and Applied Pharmacology and Toxicology Letters.
Selected publications
- Therapeutic strategy of arsenic trioxide in the fight against cancers and other diseases 2020 cited 45×
- Aptamers: an emerging navigation tool of therapeutic agents for targeted cancer therapy 2022 cited 43×
- Hyperthermia Selectively Destabilizes Oncogenic Fusion Proteins 2021 cited 40×
- Arsenic trioxide targets Hsp60, triggering degradation of p53 and survivin 2021 cited 39×
- Structural Basis of PML-RARA Oncoprotein Targeting by Arsenic Unravels a Cysteine Rheostat Controlling PML Body Assembly and Function 2023 cited 38×
- Novel insights into the role of aptamers in the fight against cancer 2019 cited 30×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering IJPM for your work?
This journal is guided by Naranmandura Hua (Prof. , Zhejiang University, Hangzhou, Zhejiang) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.